Adropin has been reported to have lipid and glucose homeostasis-regulating, angiogenesis and antiinflammatory effects in addition to preventive effects against insulin resistance and endothelial dysfunction [6,9,10,28,29]. Here, ENHO is linked to Insulin resistance.